C vs KYMR · P/E 16, rev $17.02B vs rev $99.4M
Citigroup Inc. (C) versus Kymera Therapeutics Inc (KYMR) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Kymera Therapeutics Inc (KYMR) is a biotechnology company listed on NASDAQ.
Latest reported C revenue for 2021-12-31 was $17.02B. Net income was $3.17B. Revenue was up 3.1% from 2020-12-31 to 2021-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported KYMR revenue for 2026-06-30 was $99.4M. Net income was -$130.4M. KYMR currently screens at market cap $7.39B.
C currently screens at market cap $214.73B and trailing P/E 15.5. KYMR currently screens at market cap $7.39B.
Not investment advice. Open the C and KYMR stock pages for the full models.
Not investment advice.